Edit |   |
---|---|
Antigenic Specificity | CD73, Human (Oleclumab biosimilar) |
Clone | Oleclumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, IF, IP, FCM, FuncS |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD73 Recombinant Antibody. Oleclumab (INN, development code MEDI9447) is a human monoclonal antibody targeting the ectonucleotidase CD73 that was designed for the treatment of pancreatic and colorectal and other cancers. This drug was developed by MedImmune/AstraZeneca. |
Immunogen | n/a |
Other Names | Anti-CD73 Recombinant Antibody, Research Grade Oleclumab, Anti-Human CD73 Recombinant Antibody, MEDI-9447, Antibody Drug Analogues, Monoclonal Antibody, YR1462, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1803176-05-7 |
Catalog # | YR1462 |
Price | please inquire |
Order / More Info | CD73, Human (Oleclumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |